Table:
begin	end	state
1	26	cytoplasmic
27	47	transmembrane
48	52	non-cytoplasmic
53	73	transmembrane
74	106	cytoplasmic
107	129	transmembrane
130	134	non-cytoplasmic
135	153	transmembrane
154	164	cytoplasmic
165	187	transmembrane
188	204	non-cytoplasmic
205	227	transmembrane
228	247	cytoplasmic
248	269	transmembrane
270	292	non-cytoplasmic
293	315	transmembrane
316	346	cytoplasmic
347	367	transmembrane
368	372	non-cytoplasmic
373	396	transmembrane
397	416	cytoplasmic
417	435	transmembrane
436	446	non-cytoplasmic
447	467	transmembrane
468	498	cytoplasmic

Input:
>WP_034528196.1 NCBI__GCF_000740055.1:WP_034528196.1
MEASEQVQDTELENHEVKRGLKTRHVSMIALGGCIGTGLFVASGSAISSAGPGGALVAYI
AMGMMVYFLMTSLGEMATNMPISGSFAAYSAKYVDPALGFAMGWNYWFNWAITVAVDIST
AALVIKFWLPGVPGWIWSAVALVILFVINALSVRTYGETEFWLSLIKIVTIVVFLVVGLL
TIFGIMGGHATGLENFTYKKAPFVGGFPAILSVFVVAGFSFQGTELVGITAGESEDPHKS
VPKAINQVFWRIILFYILAIAVIALIIPYTSHDLLGSSATDVAISPFTLVFQRAGLAAAA
SIMNAVILTSVLSSANSGMYASTRMLYSLAHEGYAPKAFGRTTKNGIPMLALVGTTLIAA
VTFISSIAGPQLYLWLVAASGLTGFIAWIGIAISHFRFRRAFIKQGHDLSELKYHAKWFP
IGPILALILCIGVIIGQDPASFANFNWTQILVTYISVPLVLVLYIVYKLKKHTKLIPLDE
VDVSPTTKEHKMNQQENA

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server